Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
MEDAREX INC (MEDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/04/2009 CT ORDER Form CT ORDER - Confidential treatment order
10/05/2009 15-12G/A Form 15-12G - Securities registration termination [Section 12(g)] [amend]
10/05/2009 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
09/25/2009 8-K Quarterly results
09/02/2009 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
09/01/2009 8-K Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T...
Docs: "Amended and Restated Certificate of Incorporation of Medarex, Inc.",
"Amended and Restated Bylaws of Medarex, Inc., adopted as of September 1, 2009",
"Second Supplemental Indenture, between Medarex, Inc. and Wilmington Trust Company, as trustee (relating to the 2.25% Convertible Senior Notes)"
09/01/2009 25-NSE Form 25-NSE -
09/01/2009 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/01/2009 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/28/2009 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/27/2009 SC 13D/A MEDAREX INC reports a 3.4% stake in Medarex, Inc.
08/27/2009 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/20/2009 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/19/2009 SC 13D MEDAREX INC reports a 2.8% stake in Medarex, Inc.
08/12/2009 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
08/03/2009 10-Q Quarterly Report for the period ended June 30, 2009
08/03/2009 8-K Quarterly results
Docs: "Medarex Announces 2009 Second Quarter Financial Results"
07/29/2009 8-K/A Financial Statements and Exhibits
Docs: "License, Development and Commercialization Agreement, by and among Merck Sharp & Dohme Research Ltd., University of Massachusetts, Massachusetts Biologic Laboratories, Worcester City Campus Corporation and Medarex, Inc."
07/28/2009 8-K Form 8-K - Current report
07/28/2009 SC TO-T Form SC TO-T -- Tender offer statement by Third Party
07/23/2009 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, among Bristol-Myers Squibb Company, Puma Acquisition Corporation and Medarex, Inc",
"Second Amendment to Rights Agreement, by and among Medarex, Inc. and Continental Stock Transfer & Trust Company"
06/26/2009 SC 13D/A MEDAREX INC reports a 18.7% stake in Celldex Therapeutics, Inc.
06/26/2009 S-8 Form S-8 -- Securities to be offered to employees in employee benefit plans
06/10/2009 SC 13G MAZAMA CAPITAL MANAGEMENT INC reports a 4.4% stake in OMB Number 3235-0145 Medarex Inc.
06/02/2009 8-K Other Events
05/08/2009 SC 13G Form SC 13G -- Statement of acquisition of beneficial ownership by individuals
05/05/2009 10-Q Quarterly Report for the period ended March 31, 2009
04/30/2009 8-K Form 8-K -- Current report
04/24/2009 8-K Form 8-K -- Current report
04/17/2009 ARS Form ARS -- Annual Report to Security Holders
04/06/2009 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/02/2009 10-K Annual Report for the period ended December 31, 2008
02/26/2009 TRN Medarex, Inc. Q4 2008 Earnings Call Transcript
02/25/2009 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy